Search Results
Treatment Options in Refractory mCRC
Treatment Goals in Refractory mCRC
Fruquintinib provides improvement in overall survival for refractory mCRC
Sequencing of Therapy in Refractory mCRC
Evaluating the role of fruquintinib in patients with refractory mCRC
Dose Optimization for Improved Outcomes in Refractory mCRC
Current status and perspectives on liquid biopsies in mCRC
Use of Regorafenib in Refractory mCRC
Influence of sidedness on prognosis and treatment in mCRC
Third-Line Treatment Options for mCRC
Treatment Options for KRAS-Mutant Unresectable mCRC
Treatment Beyond Progression for mCRC
